Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cefar is a prominent medical technology brand specializing in electrotherapy solutions for pain management and neuromuscular rehabilitation. Founded in 1975 in Sweden, the company became a global leader in the development of Transcutaneous Electrical Nerve Stimulation (TENS) and Neuromuscular Electrical Stimulation (NMES) devices. Its product portfolio serves a diverse range of applications, including chronic pain relief, sports injury recovery, and obstetric care. In 2007, Cefar-Compex was acquired by DJO Global, which later became Enovis, integrating Cefar's technology into a broader orthopedic and rehabilitation platform. Today, Cefar products remain a standard in clinical settings and for home-based patient care worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cefar Medical.